Trial intelligence / Profile preview

Alpha-lipoic acid in cardiac autonomic neuropathy (CANON)

NCT02056366Phase 4Completed

Sponsor
The Catholic University of Korea
Start
Jan 2010
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alpha-lipoic acid in cardiac autonomic neuropathy (CAN), sponsored by The Catholic University of Korea. Started Jan 2010; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

cardiac autonomic neuropathy (CAN)

Beyond the preview

Go deeper on NCT02056366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02056366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call